NeuroOne Medical Technologies Corp. (NMTC), a medical technology company, announced Friday that it has commenced a proposed underwritten registered public offering of its common stock.
The company will sell all of the shares in the offering and intends to grant the underwriter a 45-day option to purchase up to an additional 15 percent of the shares sold.
Ladenburg Thalmann & Co. Inc. is acting as the sole book-running manager for the offering.
Currently, NMTC is trading at $0.48 down by 43.4 percent on the Nasdaq.
For comments and feedback: editorial@rttnews.com